Assyro AI

FDA Orange Book · active-ingredient family

Cyclopentolate hydrochloride

Cyclopentolate hydrochloride is approved in 13 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

0

Brand (NDA)

13

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Generic (ANDA) products (13)

ProductApplicantApplicationTEApproved
CYCLOPENTOLATE HYDROCHLORIDESCIEGEN PHARMSANDA 205937Dec 09, 2015
AKPENTOLATERISINGANDA 040164ATJan 13, 1997
AKPENTOLATERISINGANDA 040165ATJan 13, 1997
PENTOLAIRBAUSCH AND LOMB INCANDA 040075ATApr 29, 1994
CYCLOPENTOLATE HYDROCHLORIDEALCON PHARMS LTDANDA 089162Jan 24, 1991
PENTOLAIRPHARMAFAIRANDA 088643Feb 09, 1987
PENTOLAIRPHARMAFAIRANDA 088150Feb 25, 1983
AK-PENTOLATEEPIC PHARMA LLCANDA 085555Approved Prior to Jan 1, 1982
CYCLOGYLRLDALCON LABS INCANDA 084109Approved Prior to Jan 1, 1982
CYCLOGYLRLDALCON LABS INCANDA 084110ATApproved Prior to Jan 1, 1982
CYCLOGYLRLDALCON LABS INCANDA 084108ATApproved Prior to Jan 1, 1982
CYCLOPENTOLATE HYDROCHLORIDESOLA BARNES HINDANDA 084150Approved Prior to Jan 1, 1982
CYCLOPENTOLATE HYDROCHLORIDESOLA BARNES HINDANDA 084863Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cyclopentolate hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.